CLASS II Drug recall · Reported 6 Apr 2022 · FDA Enforcement Report

Testosterone Cypionate/ Dhea *GS* 200/10MG/ML Injectable recalled

Drug Depot Inc is recalling Testosterone Cypionate/ Dhea *GS* 200/10MG/ML Injectable, distributed nationwide in the US. The recall was initiated on 23 Mar 2022 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLots: a)746000 BUD: 6/26/2022; b) 751472 BUD: 7/20/2022
Quantity recalled620 vials

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0732-2022
FDA event ID
89808
Recalling firm
Drug Depot Inc, Palm Harbor, FL
Classification
Class II
Status
Terminated
Recall initiated
23 Mar 2022
FDA classified
29 Mar 2022
Reported
6 Apr 2022
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Sterility

Timeline

23 Mar 2022Recall initiated by company
29 Mar 2022Classified by FDA+6 days
6 Apr 2022Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Lack of sterility assurance.

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

TESTOSTERONE CYPIONATE/ DHEA *GS* 200/10MG/ML Injectable, Packaged in a multi dose 10ML vial, as a) 5 ML Formula ID 115678; b) 10 ML Formula ID 115498, APS Pharmacy

Where it was distributed

Nationwide in the USA including Puerto Rico.

Nationwide Puerto Rico

Questions about this recall

Why was it recalled?

Lack of sterility assurance.

Which lots are affected?

Lots: a)746000 BUD: 6/26/2022; b) 751472 BUD: 7/20/2022

Where was it sold?

Nationwide in the USA including Puerto Rico.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

7 other products · FDA event 89808

This product is part of a recall event; the main page for the event is Testosterone Cypionate/ Anastrozole *gs* Oil 200mg/0.5mg/ML recalled.

More recalls from Drug Depot Inc

All 8

Other Testosterone Cypionate recalls

All 130